Visit to Kanghong Pharmaceutical Group by Commercial Officer William Marshak, U.S. Consulate General in Chengdu
“KeLeXing capsule” is to be included in the National Key New Products Plan
Four companies of KangHong Pharmaceutical Group awarded the "high-tech enterprise"
The people's government of sichuan province honored some enterprises gained China Famous trademarks which are represent for Kang Hong Pharmaceutical company.
Kanghong pharmaceutical group donated 1million yuan worth of medicine and other relief to earthquake-hit areas.
Sina-US GCP INSPECTION INTERNATIONAL TRAINING CLASS visit KANGHONG Pharmaceutical Group to carry out academic exchanges
Kanghong pharmaceutical group donated RMB500，000 Yuan to earthquake-hit areas.
President Ke Zunhong Attended the Third Session of the Eleventh National People’s Congress
Visit to Kanghong Pharmaceuticals Group by The Trade and Investment Department officer of UK Jon Mowles
Kanghong Pharmaceutical Group's 4 products including "Songlinxuemaikang" and "Xinluona" awarded the "Sichuan Famous Brand" honor
Kanghong Invited Authoritative Experts to Fix the Late-Phase Clinical Trials Plan of KH902
“State Significant New Drug" KH903 Entered into Phase-I Clinical Study
KH903 I clinical trial program seminars held in Guangzhou
"Fusion Protein FP3" in Kanghong Pharmaceutical Group Was Awarded Korean Patent.
Kanghong Obtained Patent of China --- Treatment of Ocular Diseases by KH902
The Patent of KH901 was Authorized in Russia
Biological Molecule Protein Drug Laboratory--- Key Laboratory in Sichuan Province
Chengdu Kanghong Pharmaceutical Group won the "corporate credit rating AAA enterprise"
Dutch Biopharmaceutical Company Delegation SU Exchange Visits to Kanghong Pharmaceutical Group
Kanghong Pharmaceutical Group to participate in the "5.12 Earthquake Education and relief operations," large-scale social welfare activities
分页：
9
7
[
1
2
3
]
8
:
